Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Archive
Global health
Authors
About
Help
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Archive
Global health
Authors
About
Help
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 14, Issue 11
Gemtuzumab-ozogamicin and blinatumomab as treatment for refractory mixed-phenotype blast crisis in chronic myeloid leukaemia
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Case report
Gemtuzumab-ozogamicin and blinatumomab as treatment for refractory mixed-phenotype blast crisis in chronic myeloid leukaemia
Online download statistics by month:
Online download statistics by month: November 2021 to September 2023
Abstract
Full
Pdf
Nov 2021
1158
16
7
Dec 2021
781
8
2
Jan 2022
189
7
2
Feb 2022
312
19
14
Mar 2022
116
2
2
Apr 2022
62
3
0
May 2022
104
5
0
Jun 2022
56
2
2
Jul 2022
43
1
0
Aug 2022
111
2
1
Sep 2022
76
4
3
Oct 2022
33
3
0
Nov 2022
117
9
6
Dec 2022
94
2
0
Jan 2023
26
0
0
Feb 2023
40
1
0
Mar 2023
78
4
3
Apr 2023
40
1
1
May 2023
32
2
0
Jun 2023
32
2
0
Jul 2023
38
1
0
Aug 2023
42
2
1
Sep 2023
28
0
0
Total
3608
96
44
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF